What does NPM1 gene do?
What does NPM1 gene do?
Normal Function The NPM1 gene provides instructions for making a protein called nucleophosmin, which is found in a small region inside the nucleus of the cell called the nucleolus. Nucleophosmin shuttles back and forth between the nucleus and the fluid surrounding it (the cytoplasm).
What is NPM1 in AML?
The nucleophosmin (NPM1) gene encodes for a ubiquitous multifunctional shuttling protein1 with predominant nucleolar localization. NPM1 is the most commonly mutated gene in adult acute myeloid leukemia (AML; ∼30% of cases).
How are mutations detected in NPM1?
There are highly specific and sensitive molecular assays available for detecting NPM1 mutations, like Sanger sequencing, high-resolution melting curve analysis, real-time polymerase chain reaction (PCR), and pyrosequencing (Pyr).
How I treat NPM1 positive AML?
The identification of new molecular subtypes within NPM1-mutated AML patients is relevant in the prediction of treatment response and outcome. Currently, most patients with a NPM1 mutation and without a FLT3-ITD mutation, are treated with conventional induction and consolidation chemotherapy.
What does NPM1 stand for?
The nucleophosmin gene (NPM1) is located on chromosome 5q35 and contains 12 exons8. The encoded protein is localized primarily in the nucleolus, but shuttles rapidly between the nucleus and cytoplasm9. NPM has been shown to play an important role in many basic cellular processes.
What is Cebpa gene?
The CEBPA gene provides instructions for making a protein called CCAAT enhancer-binding protein alpha. This protein is a transcription factor, which means that it attaches (binds) to specific regions of DNA and helps control the activity (expression) of certain genes.
Which finding is associated with a worse prognosis in AML with NPM1 mutation?
These data suggest that NPM1 mutations confer a favorable risk only in the absence of any adverse risk features. In fact, among patients with NPM1-mutant AML, the presence of adverse cytogenetics seems to yield an even worse prognosis than a concomitant FLT3-ITD mutation.
What chromosome is NPM1 on?
Human NPM1 is located on chromosome 5q35 and is composed of 12 exons, encoding for at least two isoforms (Fig.
Where is NPM1?
Nucleophosmin (NPM), also called nucleolar protein B23, numatrin, or NO38, is an abundant phosphoprotein that is ubiquitously expressed and highly conserved. The nucleophosmin gene (NPM1) is located on chromosome 5q35 and contains 12 exons8.
What type of mutation is CEBPA?
Mutations in the transcription factor CCAAT/enhancer binding protein α (CEBPA) are found in approximately 10% of cases of acute myeloid leukemia (AML). Most CEBPA-mutant AML exhibit two mutations, which frequently involve a combination of an N-terminal and a C-terminal gene mutation, typically on different alleles.
What chromosome is the CEBPA gene on?
CCAAT Enhancer Binding Protein Alpha (CEBPA) is an intronless gene located on chromosome 19q13. 15,6. It encodes protein belonging to transcription factors family containing a basic leucine zipper (bZIP) motif6,7.
What is a common myeloid blast Immunophenotype in AML with NPM1 mutation?
The most common blast phenotype in myeloid AML-NPM1 was a CD34−/HLA-DR− phenotype (69 [49%] of 141).
How are NPM1 mutations related to acute myeloid leukemia?
Approximately 50-60 percent of patients with NK-AML carry NPM1 mutations which are characterized by cytoplasmic dislocation of the NPM1 protein. In AML, mutant NPM1 (NPM1c+) acts in a dominant negative fashion and also blocks the differentiation of myeloid cells through gain-of-function for the AML phenotype.
Is the NPM1 mutation a founder genetic alteration?
Several pieces of evidence suggest the NPM1 mutation is a founder genetic alteration ( Table 2) in AML. GEP indicates gene expression profiling. Or its immunohistologic surrogate (cytoplasmic NPM, NPMc + ). Lower incidence in Chinese children. In most, but not all, studies. Less than 10% CD34 + cells.
What kind of protein is the NPM1 gene?
Blood 2020; 136 (15): 1707–1721. doi: https://doi.org/10.1182/blood.2019004226 The nucleophosmin ( NPM1) gene encodes for a multifunctional protein with prominent nucleolar localization that shuttles between nucleus and cytoplasm.
What is the microRNA signature of NPM1?
As expected for a founder genetic lesion, the NPM1 mutation defines a subgroup of AML with a distinct gene expression profile (including down-regulation of CD34 and up-regulation of HOX genes) 20-22 and microRNA signature 22-24 (including up-regulation of miR-10a and miR-10b ).
